본문으로 건너뛰기
← 뒤로

The Application of Microfluidic Chips in Primary Urological Cancer: Recent Advances and Future Perspectives.

1/5 보강
Smart medicine 2025 Vol.4(2) p. e70010
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
환자: urological diseases, especially by evaluating biomarkers for urinary malignancies
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
The application has provided diagnostic and therapeutic benefits for patients with urological diseases, especially by evaluating biomarkers for urinary malignancies. In this review, we go through the applications of OOC in BCa, Pca and Rca, and discuss the prospects of reducing the cost and improving the repeatability and amicability of the intelligent integration of urinary system organ chips.

Liu J, Zhi X, Fang X, Li W, Zhao W, Liu M

📝 환자 설명용 한 줄

The research of primary urological cancers, including bladder cancer (BCa), prostate cancer (PCa), and renal cancer (RCa), has developed rapidly.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Liu J, Zhi X, et al. (2025). The Application of Microfluidic Chips in Primary Urological Cancer: Recent Advances and Future Perspectives.. Smart medicine, 4(2), e70010. https://doi.org/10.1002/smmd.70010
MLA Liu J, et al.. "The Application of Microfluidic Chips in Primary Urological Cancer: Recent Advances and Future Perspectives.." Smart medicine, vol. 4, no. 2, 2025, pp. e70010.
PMID 40390767 ↗
DOI 10.1002/smmd.70010

Abstract

The research of primary urological cancers, including bladder cancer (BCa), prostate cancer (PCa), and renal cancer (RCa), has developed rapidly. Microfluidic technology provides a good variety of benefits compared to the heterogeneity of animal models and potential ethical issues of human study. Microfluidic technology and its application with cell culture (e.g., organ-on-a-chip, OOC) are extensively used in urological cancer studies in preclinical and clinical settings. The application has provided diagnostic and therapeutic benefits for patients with urological diseases, especially by evaluating biomarkers for urinary malignancies. In this review, we go through the applications of OOC in BCa, Pca and Rca, and discuss the prospects of reducing the cost and improving the repeatability and amicability of the intelligent integration of urinary system organ chips.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기